SRI International Chooses Instem's SEND Solutions
SRI International Deploying Submit Software Using SaaS
CONSHOHOCKEN, PA - (BUSINESS WIRE) – September 1, 2015 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that SRI International (SRI) has purchased a comprehensive suite of software solutions to support CDISC’s Standard for Exchange of Nonclinical Data (SEND).
In December 2014, the FDA issued the final Guidance for Standardized Study Data for providing regulatory submissions in electronic format. The introduction of SEND for both regulatory submission and the electronic exchange of toxicology data is having a significant impact on the industry, with many organizations increasingly turning to Instem to help them become SEND-enabled.
- SRI International to deploy submit™, a suite of integrated tools and services for the creation and management of SEND datasets and associated documents.
- SRI International’s deployment to include the SENDView application to enable simplified review of SEND datasets.
- SRI International to access submit and SENDView using Instem’s SaaS delivery model.
Mike Harwood, Senior Vice President, Instem, commented “SRI is a diverse and dynamic organization, and we are pleased to strengthen our relationship with them. Instem has the largest community of SEND clients in the world, supported by the industry’s leading SEND experts. We are delighted to welcome SRI to this established and rapidly growing community.”
Instem has been extensively involved in the creation and development of SEND since its inception, working closely with SEND pilot organizations, the FDA and industry to help define the standard and align it with industry practices. As a result of this detailed involvement, Instem developed the first adopted set of complete SEND management tools in the market, with Instem SEND solutions now licensed across 12 countries at over 34 sites.
About SRI International
SRI International creates world-changing solutions to make people safer, healthier, and more productive. SRI, a research center headquartered in Menlo Park, California, works primarily in advanced technology and systems, biosciences, computing, and education. SRI brings its innovations to the marketplace through technology licensing, spin-off ventures and new product solutions.
Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.
Meeting clients at the intersection of investment & return™.
Gary Mitchell (US HQ)
Julie Jones (UK HQ)
Tel: +44 (0) 1785 825600